Safety and efficacy of direct oral anticoagulants (DOACs) vs low molecular weight heparin (LMWH) in malignancy induced venous thromboembolism-a systematic review and meta analysis

Lignende værker

• Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?
  af: Leentjens, Jenneke, et al.
  Udgivet: (2017)
• Safety and efficacy of direct oral anticoagulants (DOACs) vs warfarin in patients with concurrent atrial fibrillation and bioprosthetic mitral or aortic valve replacement-a meta analysis
  af: Abdul Razzack, A, et al.
  Udgivet: (2021)
• Direct Oral Anticoagulant (DOAC) versus Low-Molecular-Weight Heparin (LMWH) for Treatment of Cancer Associated Thrombosis (CAT): A Systematic Review and Meta-Analysis
  af: Li, Ang, et al.
  Udgivet: (2018)
• Beware of thromboembolic risk in obese patients on direct oral anticoagulants (DOACs)
  af: Chattopadhyay, Indrajit, et al.
  Udgivet: (2018)
• Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism
  af: Smythe, Maureen A., et al.
  Udgivet: (2016)